JP2015508780A5 - - Google Patents

Download PDF

Info

Publication number
JP2015508780A5
JP2015508780A5 JP2014557870A JP2014557870A JP2015508780A5 JP 2015508780 A5 JP2015508780 A5 JP 2015508780A5 JP 2014557870 A JP2014557870 A JP 2014557870A JP 2014557870 A JP2014557870 A JP 2014557870A JP 2015508780 A5 JP2015508780 A5 JP 2015508780A5
Authority
JP
Japan
Prior art keywords
use according
composition
administering
immunocompromised patients
inhaler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014557870A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015508780A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/026754 external-priority patent/WO2013123521A1/en
Publication of JP2015508780A publication Critical patent/JP2015508780A/ja
Publication of JP2015508780A5 publication Critical patent/JP2015508780A5/ja
Pending legal-status Critical Current

Links

JP2014557870A 2012-02-17 2013-02-19 免疫不全患者のインフルエンザ及びパラインフルエンザウイルスを処置するための方法、化合物、及び組成物 Pending JP2015508780A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261600545P 2012-02-17 2012-02-17
US61/600,545 2012-02-17
US201261727627P 2012-11-16 2012-11-16
US61/727,627 2012-11-16
PCT/US2013/026754 WO2013123521A1 (en) 2012-02-17 2013-02-19 Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients

Publications (2)

Publication Number Publication Date
JP2015508780A JP2015508780A (ja) 2015-03-23
JP2015508780A5 true JP2015508780A5 (OSRAM) 2016-04-21

Family

ID=48984833

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014557870A Pending JP2015508780A (ja) 2012-02-17 2013-02-19 免疫不全患者のインフルエンザ及びパラインフルエンザウイルスを処置するための方法、化合物、及び組成物

Country Status (9)

Country Link
US (4) US20130280332A1 (OSRAM)
EP (1) EP2841092B1 (OSRAM)
JP (1) JP2015508780A (OSRAM)
CN (2) CN109529026A (OSRAM)
AU (3) AU2013221230A1 (OSRAM)
CA (1) CA2864746A1 (OSRAM)
ES (1) ES2970401T3 (OSRAM)
IL (2) IL234116B (OSRAM)
WO (1) WO2013123521A1 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2799403C (en) 2010-05-14 2020-01-21 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating leukemia
US9301962B2 (en) 2010-05-14 2016-04-05 Baylor College Of Medicine Male contraceptive compositions and methods of use
DK2571503T3 (en) 2010-05-14 2015-04-20 Dana Farber Cancer Inst Inc COMPOSITIONS AND THEIR USE IN THE TREATMENT OF NEOPLASIA, INFLAMMATORY DISEASE AND OTHER DISORDERS
CA2918910A1 (en) 2013-07-25 2015-01-29 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
EP3066101B1 (en) 2013-11-08 2020-07-29 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
CN106029653A (zh) 2014-01-31 2016-10-12 达纳-法伯癌症研究所股份有限公司 二氨基嘧啶苯砜衍生物及其用途
US10793571B2 (en) 2014-01-31 2020-10-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
MX377534B (es) 2014-02-28 2025-03-10 Tensha Therapeutics Inc Compuestos para usarse en el tratamiento de hiperinsulinemia.
MX2017001757A (es) 2014-08-08 2017-05-30 Dana Farber Cancer Inst Inc Derivados de dihidropteridinona y sus usos.
MX2017001756A (es) 2014-08-08 2017-05-30 Dana Farber Cancer Inst Inc Derivados de diazepano y sus usos.
EA033325B1 (ru) 2014-10-27 2019-09-30 Тэнша Терапеутикс, Инк. Ингибиторы бромодомена
EP3885343A1 (en) 2014-11-06 2021-09-29 Dana-Farber Cancer Institute, Inc. Indole compounds as ezh2 inhibitors and uses thereof
JP2017533922A (ja) * 2014-11-06 2017-11-16 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド 移植片対宿主病(gvhd)のためのクロマチン構造を調節する組成物の使用
WO2016200916A1 (en) * 2015-06-08 2016-12-15 Ansun Biopharma, Inc. Treatment of human metapneumovirus
US10702527B2 (en) 2015-06-12 2020-07-07 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
CR20180199A (es) 2015-09-11 2018-05-25 Dana Farber Cancer Inst Inc Acetamida tienotriazolodiazepinas y usos de las mismas
HK1256417A1 (zh) 2015-09-11 2019-09-20 达纳-法伯癌症研究所股份有限公司 氰基噻吩並三唑並二氮雜環庚三烯及其用途
RU2742035C2 (ru) 2015-11-25 2021-02-01 Дана-Фарбер Кэнсер Инститьют, Инк. Бивалентные ингибиторы бромодоменов и пути их применения
US10633371B2 (en) 2016-04-22 2020-04-28 Dana-Farber Cancer Institute, Inc. EZH2 inhibitors and uses thereof
CA3162719A1 (en) * 2019-11-25 2021-06-03 Ansun Biopharma, Inc. Immune cell delivery of sialidase to cancer cells, immune cells and the tumor microenvironment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8245708B2 (en) * 2002-05-07 2012-08-21 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
WO2004022128A2 (en) * 2002-09-06 2004-03-18 Chrysalis Technologies Incorporated Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
KR20090087971A (ko) 2002-11-22 2009-08-18 유 망 광범위 스펙트럼의 항-바이러스 치료제 및 예방제
US7807174B2 (en) 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
KR102109867B1 (ko) * 2006-01-24 2020-05-13 안선 바이오파르마, 아이엔씨. 고분자 미소 구체들의 조제를 위한 기술
JP2013510169A (ja) 2009-11-06 2013-03-21 ネクスバイオ,インク. 呼吸器管の治療及び予防のための方法、化合物、及び組成物

Similar Documents

Publication Publication Date Title
JP2015508780A5 (OSRAM)
IL273194B2 (en) Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients
BR112013028572B8 (pt) Bocais para distribuição de droga nasal
EA200802012A1 (ru) Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением
PH12014502662A1 (en) Novel dosage form and formulation of abediterol
IL216468B (en) Pharmaceutical compositions deliverable from a metered dose inhaler comprising glycopyrrolate and formoterol and their use in treatment of pulmonary diseases
CN204502085U (zh) 呼吸内科用喷药器
PH12014500551A1 (en) Pharmaceutical composition for inhalation
MX377175B (es) Solucion para inhalacion de tiotropio, administrada en forma nebulizada y el uso de la misma para tratar enfermedad pulmonar obstructiva crónica (epoc).
JP2014528470A5 (OSRAM)
MX2021006585A (es) Ciclosporina a en forma solubilizada en liposomas (l-csa) para usarse en el tratamiento de enfermedades pulmonares mediante la inhalación de un aerosol generado por un nebulizador.
WO2012047182A3 (en) Single dose dry powder inhalation device
JP2014530231A5 (OSRAM)
EA202091199A1 (ru) Лекарственное средство для предотвращения или лечения риновирусной инфекции
MX2018013475A (es) Acido carboxilico para tratar/prevenir congestion nasal.
CN204092782U (zh) 一种医用雾化器
MX2020010977A (es) Procedimientos de tratamiento de infecciones fúngicas.
JP2013522295A5 (OSRAM)
CN204233551U (zh) 辅助呼吸气雾气体的装置
BR112013020632A8 (pt) Composição farmacêutica para a administração tópica
EA201201394A1 (ru) Ингалятор для доставки лекарственного средства в виде сухого порошка
PH12020552075A1 (en) Hepatitis b vaccine transnasal administration system
AR094287A1 (es) Metodos y composiciones para administracion de oxibutinina
EP4005565A1 (en) Novel uses of adamantane derivatives
CN203436639U (zh) 一种雾化器